Merus (NASDAQ:MRUS) Receives $42.67 Average PT from Brokerages

Shares of Merus (NASDAQ:MRUS – Get Rating) have earned a consensus rating of “Moderate Buy” from the ten research firms that are covering the firm, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell recommendation and seven have given a buy recommendation to the company. The average 1 year price target […]

Related Keywords

Netherlands ,Stifel Nicolaus ,Platinum Investment Management Ltd ,Pura Vida Investments ,Citigroup ,Tekla Capital Management ,Tudor Investment Corp Et Al ,Get Rating ,Marketbeat Ratings ,Vida Investments ,Capital Management ,Investment Management ,Exoduspoint Capital Management ,Stock Down ,Ton Logtenberg ,Hennie Hoogenboom ,Merus Daily ,Emerus ,Nasdaq Mrus ,Imrus ,Medical ,Ratings ,Consensus ,